These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 1980838

  • 1. Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study.
    Bernardini GL, Speciale SG, German DC.
    Brain Res; 1990 Sep 10; 527(1):123-9. PubMed ID: 1980838
    [Abstract] [Full Text] [Related]

  • 2. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
    Manaye KF, Sonsalla PK, Barnett G, Heikkila RE, Woodward DJ, Smith WK, German DC.
    Brain Res; 1989 Jul 10; 491(2):307-15. PubMed ID: 2765888
    [Abstract] [Full Text] [Related]

  • 3. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
    Abdel-Wahab MH.
    J Biochem Mol Toxicol; 2005 Jul 10; 19(1):32-41. PubMed ID: 15736157
    [Abstract] [Full Text] [Related]

  • 4. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
    German DC, Nelson EL, Liang CL, Speciale SG, Sinton CM, Sonsalla PK.
    Neurodegeneration; 1996 Dec 10; 5(4):299-312. PubMed ID: 9117541
    [Abstract] [Full Text] [Related]

  • 5. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV, Heikkila RE, Nicklas WJ.
    J Pharmacol Exp Ther; 1987 Sep 10; 242(3):858-63. PubMed ID: 3498818
    [Abstract] [Full Text] [Related]

  • 6. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT, Irwin I, Delanney LE, Langston JW.
    J Pharmacol Exp Ther; 1995 May 10; 273(2):716-20. PubMed ID: 7752075
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK, Youngster SK, Kindt MV, Heikkila RE.
    J Pharmacol Exp Ther; 1987 Sep 10; 242(3):850-7. PubMed ID: 2888874
    [Abstract] [Full Text] [Related]

  • 8. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
    Liang CL, Sinton CM, Sonsalla PK, German DC.
    Neurodegeneration; 1996 Dec 10; 5(4):313-8. PubMed ID: 9117542
    [Abstract] [Full Text] [Related]

  • 9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC, Dubach M, Askari S, Speciale SG, Bowden DM.
    Neuroscience; 1988 Jan 10; 24(1):161-74. PubMed ID: 3259295
    [Abstract] [Full Text] [Related]

  • 10. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y, Emori K, Ashby CR.
    Synapse; 1996 Jan 10; 22(1):46-53. PubMed ID: 8822477
    [Abstract] [Full Text] [Related]

  • 11. Neurotoxicity of an MPTP analogue, 2'CH3-MPTP, on monoaminergic systems in the mouse brain.
    Gupta M, Chen XL.
    Ann N Y Acad Sci; 1992 May 11; 648():283-5. PubMed ID: 1353331
    [No Abstract] [Full Text] [Related]

  • 12. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y, Schechter L, Hashimoto K, Shirayama Y, Ashby CR.
    Synapse; 2003 Dec 01; 50(3):181-90. PubMed ID: 14515335
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment.
    Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, Mitrofanis J.
    J Comp Neurol; 2010 Jan 01; 518(1):25-40. PubMed ID: 19882716
    [Abstract] [Full Text] [Related]

  • 14. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys.
    Masilamoni GJ, Groover O, Smith Y.
    Neurobiol Dis; 2017 Apr 01; 100():9-18. PubMed ID: 28042095
    [Abstract] [Full Text] [Related]

  • 15. The metabolic rate and vulnerability of dopaminergic neurons, and adenosine dynamics in the cerebral cortex, nucleus accumbens, caudate nucleus, and putamen of the common marmoset.
    Nomoto M, Kaseda S, Iwata S, Shimizu T, Fukuda T, Nakagawa S.
    J Neurol; 2000 Sep 01; 247 Suppl 5():V16-22. PubMed ID: 11081800
    [Abstract] [Full Text] [Related]

  • 16. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
    Herrero MT, Perez-Otaño I, Oset C, Kastner A, Hirsch EC, Agid Y, Luquin MR, Obeso JA, Del Rio J.
    Neuroscience; 1993 Oct 01; 56(4):965-72. PubMed ID: 7904332
    [Abstract] [Full Text] [Related]

  • 17. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
    German DC, Manaye KF, Sonsalla PK, Brooks BA.
    Ann N Y Acad Sci; 1992 May 11; 648():42-62. PubMed ID: 1353337
    [Abstract] [Full Text] [Related]

  • 18. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K, Suzuki K, McCreary AC, Ashby CR.
    Synapse; 2006 May 11; 59(6):359-67. PubMed ID: 16463399
    [Abstract] [Full Text] [Related]

  • 19. Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain.
    Seroogy KB, Fallon JH.
    J Comp Neurol; 1989 Jan 15; 279(3):415-35. PubMed ID: 2918078
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
    Ashby CR, Pan H, Minabe Y, Toor A, Fishkin L, Wang RY.
    Synapse; 1995 Aug 15; 20(4):351-61. PubMed ID: 7482294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.